CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Repros Therapeutics

For profitWebsite ↗

Also known as: Repros Therapeutics Inc. | Zonagen

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2006

Last known activity

Jun 1, 2016

Acquired by Allergan PLC (2015) → AbbVie on Dec 1, 2017

Timeline

2000s

  1. Jan 1, 2006

    Repros Therapeutics— Founded

2010s

  1. Dec 1, 2017

    Allergan PLC (2015)— Acquired By

  2. Jun 26, 2019

    AbbVie— Now

Drugs by trial phase (8 distinct, 59 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (50)

Details

Founded
The Woodlands, TX, US Jan 1, 2006
Last known activity
Jun 1, 2016

Notes

Repros is now operating as a subsidiary of Allergan